EcoDrugPlus

Carbonic Anhydrase 1

Ensembl ID : ENSCDRG00005017325
Gene Symbol: CA1
3 Cross references
288 Possible Orthologues:

Carbonic Anhydrase 12

Ensembl ID : ENSCDRG00005003913
Gene Symbol: CA12
3 Cross references
215 Possible Orthologues:

Carbonic Anhydrase 13

Ensembl ID : ENSCDRG00005017285
Gene Symbol: CA13
3 Cross references
291 Possible Orthologues:

Carbonic Anhydrase 14

Ensembl ID : ENSCDRG00005016386
Gene Symbol: CA14
3 Cross references
211 Possible Orthologues:

Carbonic Anhydrase 2

Ensembl ID : ENSCDRG00005017485
Gene Symbol: CA2
1 Cross references
285 Possible Orthologues:

Carbonic Anhydrase 3

Ensembl ID : ENSCDRG00005017409
Gene Symbol: CA3
3 Cross references
310 Possible Orthologues:

Carbonic Anhydrase 4

Ensembl ID : ENSCDRG00005006611
Gene Symbol: CA4
3 Cross references
333 Possible Orthologues:

Carbonic Anhydrase 5a

Ensembl ID : ENSCDRG00005020666
Gene Symbol: CA5A
3 Cross references
170 Possible Orthologues:

Carbonic Anhydrase 5b

Ensembl ID : ENSCDRG00005013388
Gene Symbol: CA5B
1 Cross references
219 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSCDRG00005011617
Gene Symbol: CA6
1 Cross references
227 Possible Orthologues:

Carbonic Anhydrase 7

Ensembl ID : ENSCDRG00005007047
Gene Symbol: CA7
1 Cross references
221 Possible Orthologues:

Carbonic Anhydrase 9

Ensembl ID : ENSCDRG00005005379
Gene Symbol: CA9
1 Cross references
283 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).